Scotland Yard probes Big Pharma meds in Reckitt's boxes

Scotland Yard is investigating whether boxes of Reckitt Benckiser's painkiller Nurofen were sabotaged. The company on Friday recalled three lots of Nurofen Plus, after London patients found cut-down blister strips of the AstraZeneca ($AZN) antipsychotic drug Seroquel in their boxes (and two patients reportedly took the Seroquel by mistake). The recall was broadened after Pfizer's ($PFE) epilepsy and pain drug Neurontin turned up in another box in Northern Ireland.

Scotland Yard's Specialist Crime Directorate has launched an investigation, the Herald Scotland reports. The inquiry will look at Reckitt's entire supply-and-production chain to determine how the Nurofen Plus boxes ended up with Big Pharma prescription drugs--manufactured and packaged in entirely different facilities--inside them. In the meantime, Reckitt is taking back all of the Nurofen packages on the market.

"Sabotage is suspected," a spokesman for Reckitt told the Herald, "and we are working with the police on a formal investigation to find the person or persons responsible." In the meantime, the company is completely halting distribution of the drug.

- read the Herald story
- get more from Reuters

Suggested Articles

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.

Trodelvy's bladder cancer data look weaker compared with what Seattle Genetics' rival drug Padcev achieved in its own trial.

Merck’s Keytruda is battling Bristol Myers' Opdivo in adjuvant melanoma, and it just racked up trial results that will help it even the playing field.